Treatment Modification Aids Chemo Tolerability in Seniors With Advanced Cancer
WEDNESDAY, Feb. 28, 2024 (HealthDay News) — Primary treatment modification is associated...
Read More
Hematology/Oncology
FDA: Food Packaging Containing PFAS No Longer Sold in the United States
WEDNESDAY, Feb. 28, 2024 (HealthDay News) — The U.S. Food and Drug Administration announced...
Read More
Increased Cancer Risk Seen in Families of Men With Subfertility
MONDAY, Feb. 26, 2024 (HealthDay News) — Families of men with subfertility have increased...
Read More
Multitarget Fecal Immunochemical Test Increases Detection of Advanced Adenoma
MONDAY, Feb. 26, 2024 (HealthDay News) — The multitarget fecal immunochemical test (mtFIT),...
Read More
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
FRIDAY, Feb. 23, 2024 (HealthDay News) — Clinician recommendations are the most significant...
Read More
Tislelizumab Plus Chemotherapy Beneficial for Resectable NSCLC
FRIDAY, Feb. 23, 2024 (HealthDay News) — For patients with resectable non-small cell lung...
Read More
Review: Menthol Cigarette Bans Promote Smoking Cessation
THURSDAY, Feb. 22, 2024 (HealthDay News) — Menthol cigarette bans promote smoking cessation,...
Read More
Rusfertide Treatment Beneficial for Patients With Polycythemia Vera
THURSDAY, Feb. 22, 2024 (HealthDay News) — For patients with polycythemia vera, rusfertide...
Read More
Outcomes Similar for Therapy-Related, De Novo MDS After Haplo-HSCT
WEDNESDAY, Feb. 21, 2024 (HealthDay News) — Patients with therapy-related myelodysplastic...
Read More
Worse Overall Survival Seen for Adults With Leukemia With CNS Involvement
WEDNESDAY, Feb. 21, 2024 (HealthDay News) — For adults with acute myeloid leukemia (AML),...
Read More
Amtagvi Approved by the FDA for Treatment of Advanced Melanoma
TUESDAY, Feb. 20, 2024 (HealthDay News) — Amtagvi (lifileucel) has been approved by the U.S....
Read More
Antihypertensive Combos Recommended for BTKi-Linked Hypertension
FRIDAY, Feb. 16, 2024 (HealthDay News) — Specific combinations of antihypertensives are...
Read More
Brain Cancer Risk Increased After Moderate/Severe, Penetrating TBI
FRIDAY, Feb. 16. 2024 (HealthDay News) — Moderate/severe and penetrating traumatic brain...
Read More
Risk Stratification Can Predict Outcomes for CAR T-Cell Therapy in Lymphoma
THURSDAY, Feb. 15, 2024 (HealthDay News) — For patients with diffuse large B-cell lymphoma...
Read More
FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
THURSDAY, Feb. 15, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Low-Dose Positron Emission Mammography Helps ID Breast Cancer
WEDNESDAY, Feb. 14, 2024 (HealthDay News) — Low-dose positron emission mammography (PEM) is...
Read More
38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
WEDNESDAY, Feb. 14, 2024 (HealthDay News) — In 2022, 38.6 percent of children aged 9 to 17...
Read More
Pembrolizumab Improves Event-Free Survival in Early NSCLC
TUESDAY, Feb. 13, 2024 (HealthDay News) — For patients with early-stage non-small cell lung...
Read More
Sleep Apnea Prevalent Among Cardio-Oncology Patients
MONDAY, Feb. 12, 2024 (HealthDay News) — Sleep apnea is prevalent among 35 percent of...
Read More
Triplet Therapy Including Belamaf Prolongs Survival in Multiple Myeloma
FRIDAY, Feb. 9, 2024 (HealthDay News) — For patients with relapsed or refractory multiple...
Read More